Next Article in Journal
Study on Synergistic Treatment of Pancreatic Cancer by Multiple Small Interfering Ribonucleic Acid Lipid Nanoparticles of Disk Domain Receptor 1, Transforming Growth Factor β1, Tumor-Associated Calcium Signal Transduction Protein 2, and Polyligand Proteoglycan 1
Previous Article in Journal
RAS Inhibitors: Changing the Paradigm from the Undruggable
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 18
Issue 7
10.3390/pharmaceutics18070774
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite
Correction to Pharmaceutics 2019, 11(12), 631.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Franco et al. PCL/Mesoglycan Devices Obtained by Supercritical Foaming and Impregnation. Pharmaceutics 2019, 11, 631

by
Paola Franco
1,
Raffaella Belvedere
2,
Emanuela Pessolano
2,
Sara Liparoti
1,
Roberto Pantani
1,
Antonello Petrella
2,* and
Iolanda De Marco
1,*
1
Department of Industrial Engineering, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, SA, Italy
2
Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, SA, Italy
*
Authors to whom correspondence should be addressed.
Pharmaceutics 2026, 18(7), 774; https://doi.org/10.3390/pharmaceutics18070774 (registering DOI)
Submission received: 9 June 2026 / Accepted: 19 June 2026 / Published: 25 June 2026
Browse Figure
Versions Notes
  • Error in Figure
In the original publication [1], there was a mistake in Figure 11b as published. During figure preparation, the HaCaT control image (ctrl) was inadvertently misallocated. The corrected Figure 11b appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Franco, P.; Belvedere, R.; Pessolano, E.; Liparoti, S.; Pantani, R.; Petrella, A.; De Marco, I. PCL/Mesoglycan Devices Obtained by Supercritical Foaming and Impregnation. Pharmaceutics 2019, 11, 631. [Google Scholar] [CrossRef] [PubMed]
Pharmaceutics 18 00774 g011
Figure 11. (a) Histograms representing the analysis of in vitro wound-healing assay on HaCaT, BJ, and HUVEC cells treated or not with pure MSG, and PCL-derived MSG harvested at 24, 48, and 72 h, all of them at a final concentration of 50 μg/mL. (b) Invasion assay on the same cell lines with the relative representative images. Bar = 150 μm. (c) Representative images of tube formation by HUVEC cells seeded for 12 h on matrigel: EBM-2 1:1 and treated or not with pure MSG, and PCL-derived MSG. Analysis of tube length and number of branches calculated by ImageJ (Angiogenesis Analyzer tool) software. Bar = 100 μm. The values reported in the graphs are the mean ± SEM from three independent experiments performed in triplicates. Results appeared significant based on Student’s t-test, assuming a 2-tailed distribution and unequal variance. *** p < 0.001 and ** p < 0.01 vs. not treated cells.
Figure 11. (a) Histograms representing the analysis of in vitro wound-healing assay on HaCaT, BJ, and HUVEC cells treated or not with pure MSG, and PCL-derived MSG harvested at 24, 48, and 72 h, all of them at a final concentration of 50 μg/mL. (b) Invasion assay on the same cell lines with the relative representative images. Bar = 150 μm. (c) Representative images of tube formation by HUVEC cells seeded for 12 h on matrigel: EBM-2 1:1 and treated or not with pure MSG, and PCL-derived MSG. Analysis of tube length and number of branches calculated by ImageJ (Angiogenesis Analyzer tool) software. Bar = 100 μm. The values reported in the graphs are the mean ± SEM from three independent experiments performed in triplicates. Results appeared significant based on Student’s t-test, assuming a 2-tailed distribution and unequal variance. *** p < 0.001 and ** p < 0.01 vs. not treated cells.
Pharmaceutics 18 00774 g011
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Franco, P.; Belvedere, R.; Pessolano, E.; Liparoti, S.; Pantani, R.; Petrella, A.; De Marco, I. Correction: Franco et al. PCL/Mesoglycan Devices Obtained by Supercritical Foaming and Impregnation. Pharmaceutics 2019, 11, 631. Pharmaceutics 2026, 18, 774. https://doi.org/10.3390/pharmaceutics18070774

AMA Style

Franco P, Belvedere R, Pessolano E, Liparoti S, Pantani R, Petrella A, De Marco I. Correction: Franco et al. PCL/Mesoglycan Devices Obtained by Supercritical Foaming and Impregnation. Pharmaceutics 2019, 11, 631. Pharmaceutics. 2026; 18(7):774. https://doi.org/10.3390/pharmaceutics18070774

Chicago/Turabian Style

Franco, Paola, Raffaella Belvedere, Emanuela Pessolano, Sara Liparoti, Roberto Pantani, Antonello Petrella, and Iolanda De Marco. 2026. "Correction: Franco et al. PCL/Mesoglycan Devices Obtained by Supercritical Foaming and Impregnation. Pharmaceutics 2019, 11, 631" Pharmaceutics 18, no. 7: 774. https://doi.org/10.3390/pharmaceutics18070774

APA Style

Franco, P., Belvedere, R., Pessolano, E., Liparoti, S., Pantani, R., Petrella, A., & De Marco, I. (2026). Correction: Franco et al. PCL/Mesoglycan Devices Obtained by Supercritical Foaming and Impregnation. Pharmaceutics 2019, 11, 631. Pharmaceutics, 18(7), 774. https://doi.org/10.3390/pharmaceutics18070774

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop